Uniprot AC Entrez ID Gene Name Disease Cell Type PTM Type State Position PMID P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Phosphorylation N S61 P50570 1785 DNM2 DYN2 Glioblastoma multiforme Phosphorylation N S61 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Ubiquitination N K87 P50570 1785 DNM2 DYN2 Myopathy Ubiquitination N K87 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Ubiquitination N K90 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Ubiquitination N K113 P50570 1785 DNM2 DYN2 Head and neck squamous cell carcinoma Ubiquitination N K113 P50570 1785 DNM2 DYN2 Renal cell carcinoma Ubiquitination N K113 P50570 1785 DNM2 DYN2 Stomach adenocarcinoma Ubiquitination N K113 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Phosphorylation N S116 P50570 1785 DNM2 DYN2 Head and neck squamous cell carcinoma Phosphorylation N S116 P50570 1785 DNM2 DYN2 Stomach adenocarcinoma Phosphorylation N S116 P50570 1785 DNM2 DYN2 Bladder urothelial carcinoma Phosphorylation N S126 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Phosphorylation N S126 P50570 1785 DNM2 DYN2 Head and neck squamous cell carcinoma Phosphorylation N S126 P50570 1785 DNM2 DYN2 Stomach adenocarcinoma Phosphorylation N S126 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Phosphorylation N T200 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Ubiquitination N K206 P50570 1785 DNM2 DYN2 Breast adenocarcinoma Phosphorylation N T214 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Phosphorylation N T214 P50570 1785 DNM2 DYN2 Breast adenocarcinoma Methylation N R217 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Methylation N R217 P50570 1785 DNM2 DYN2 Breast adenocarcinoma Ubiquitination N K223 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Ubiquitination N K223 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Phosphorylation N Y231 P50570 1785 DNM2 DYN2 Head and neck squamous cell carcinoma Phosphorylation N Y231 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Acetylation N K240 P50570 1785 DNM2 DYN2 Head and neck squamous cell carcinoma Acetylation N K240 P50570 1785 DNM2 DYN2 Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K257 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Ubiquitination N K257 P50570 1785 DNM2 DYN2 Colon adenocarcinoma Ubiquitination N K257 P50570 1785 DNM2 DYN2 Myopathy Ubiquitination N K257 P50570 1785 DNM2 DYN2 Skin cutaneous melanoma Ubiquitination N K257 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Phosphorylation N T280 P50570 1785 DNM2 DYN2 Lung adenocarcinoma Phosphorylation N T280 P50570 1785 DNM2 DYN2 Myopathy Phosphorylation N T280 P50570 1785 DNM2 DYN2 Breast invasive carcinoma Phosphorylation N T286 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Phosphorylation N T286 P50570 1785 DNM2 DYN2 Lung adenocarcinoma Phosphorylation N T286 P50570 1785 DNM2 DYN2 Uterine corpus endometrial carcinoma Phosphorylation N T286 P50570 1785 DNM2 DYN2 Breast invasive carcinoma Phosphorylation N S292 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Phosphorylation N S292 P50570 1785 DNM2 DYN2 Colon adenocarcinoma Phosphorylation N S292 P50570 1785 DNM2 DYN2 Myopathy Phosphorylation N S292 P50570 1785 DNM2 DYN2 Prostate adenocarcinoma Phosphorylation N S292 P50570 1785 DNM2 DYN2 Stomach adenocarcinoma Phosphorylation N S292 P50570 1785 DNM2 DYN2 Uterine corpus endometrial carcinoma Phosphorylation N S292 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Acetylation N K299 P50570 1785 DNM2 DYN2 Colon adenocarcinoma Acetylation N K299 P50570 1785 DNM2 DYN2 Head and neck squamous cell carcinoma Acetylation N K299 P50570 1785 DNM2 DYN2 Myopathy Acetylation N K299 P50570 1785 DNM2 DYN2 Prostate adenocarcinoma Acetylation N K299 P50570 1785 DNM2 DYN2 Stomach adenocarcinoma Acetylation N K299 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Ubiquitination N K299 P50570 1785 DNM2 DYN2 Colon adenocarcinoma Ubiquitination N K299 P50570 1785 DNM2 DYN2 Head and neck squamous cell carcinoma Ubiquitination N K299 P50570 1785 DNM2 DYN2 Myopathy Ubiquitination N K299 P50570 1785 DNM2 DYN2 Prostate adenocarcinoma Ubiquitination N K299 P50570 1785 DNM2 DYN2 Stomach adenocarcinoma Ubiquitination N K299 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Ubiquitination N K315 P50570 1785 DNM2 DYN2 Myopathy Ubiquitination N K315 P50570 1785 DNM2 DYN2 Bladder urothelial carcinoma Phosphorylation N S347 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Phosphorylation N S347 P50570 1785 DNM2 DYN2 Renal cell carcinoma Phosphorylation N S347 P50570 1785 DNM2 DYN2 Bladder urothelial carcinoma Phosphorylation N T353 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Phosphorylation N T353 P50570 1785 DNM2 DYN2 Renal cell carcinoma Phosphorylation N T353 P50570 1785 DNM2 DYN2 Bladder urothelial carcinoma Phosphorylation N S357 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Phosphorylation N S357 P50570 1785 DNM2 DYN2 Renal cell carcinoma Phosphorylation N S357 P50570 1785 DNM2 DYN2 Uterine corpus endometrial carcinoma Phosphorylation N S357 P50570 1785 DNM2 DYN2 Lethal congenital contracture syndrome Ubiquitination N K376 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Ubiquitination N K382 P50570 1785 DNM2 DYN2 Hepatocellular carcinoma Ubiquitination N K382 P50570 1785 DNM2 DYN2 Lethal congenital contracture syndrome Ubiquitination N K382 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Ubiquitination N K393 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Phosphorylation N T400 P50570 1785 DNM2 DYN2 Rectum adenocarcinoma Phosphorylation N T400 P50570 1785 DNM2 DYN2 Uterine corpus endometrial carcinoma Phosphorylation N T400 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Phosphorylation C T404 P50570 1785 DNM2 DYN2 Rectum adenocarcinoma Phosphorylation N T404 P50570 1785 DNM2 DYN2 Uterine corpus endometrial carcinoma Phosphorylation N T404 P50570 1785 DNM2 DYN2 Colon adenocarcinoma Ubiquitination N K414 P50570 1785 DNM2 DYN2 Bladder urothelial carcinoma Phosphorylation N Y449 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Phosphorylation N Y449 P50570 1785 DNM2 DYN2 Myopathy Phosphorylation N Y449 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Phosphorylation N Y463 P50570 1785 DNM2 DYN2 Myopathy Phosphorylation N Y463 P50570 1785 DNM2 DYN2 Myopathy Phosphorylation N T527 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Phosphorylation N S532 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Acetylation N K562 P50570 1785 DNM2 DYN2 Myopathy Acetylation N K562 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Phosphorylation N Y563 P50570 1785 DNM2 DYN2 Myopathy Phosphorylation N Y563 P50570 1785 DNM2 DYN2 Bladder urothelial carcinoma Ubiquitination N K577 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Ubiquitination N K577 P50570 1785 DNM2 DYN2 Bladder urothelial carcinoma Phosphorylation N S581 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Phosphorylation N S581 P50570 1785 DNM2 DYN2 Skin cutaneous melanoma Phosphorylation N S581 P50570 1785 DNM2 DYN2 Myopathy Phosphorylation N T591 P50570 1785 DNM2 DYN2 Skin cutaneous melanoma Phosphorylation N T591 P50570 1785 DNM2 DYN2 Myopathy Phosphorylation N Y597 P50570 1785 DNM2 DYN2 Non-Hodgkin's lymphoma Phosphorylation N Y597 P50570 1785 DNM2 DYN2 Myopathy Acetylation N K598 P50570 1785 DNM2 DYN2 Non-Hodgkin's lymphoma Acetylation N K598 P50570 1785 DNM2 DYN2 Myopathy Ubiquitination N K598 P50570 1785 DNM2 DYN2 Non-Hodgkin's lymphoma Ubiquitination N K598 P50570 1785 DNM2 DYN2 Bladder urothelial carcinoma Ubiquitination N K617 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Ubiquitination N K617 P50570 1785 DNM2 DYN2 Myopathy Ubiquitination N K617 P50570 1785 DNM2 DYN2 Severe X-linked myotubular myopathy Ubiquitination N K617 P50570 1785 DNM2 DYN2 Bladder urothelial carcinoma Phosphorylation N S619 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Phosphorylation N S619 P50570 1785 DNM2 DYN2 Myopathy Phosphorylation N S619 P50570 1785 DNM2 DYN2 Severe X-linked myotubular myopathy Phosphorylation N S619 P50570 1785 DNM2 DYN2 Myopathy Phosphorylation N Y626 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Phosphorylation N S644 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Phosphorylation N S662 P50570 1785 DNM2 DYN2 Ovarian serous cystadenocarcinoma Phosphorylation N S662 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Phosphorylation N Y663 P50570 1785 DNM2 DYN2 Ovarian serous cystadenocarcinoma Phosphorylation N Y663 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Ubiquitination N K669 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Phosphorylation N T755 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Phosphorylation N S759 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Phosphorylation N S761 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Phosphorylation N S762 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Phosphorylation C S764 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Phosphorylation N S764 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Phosphorylation N T766 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Methylation N R785 P50570 1785 DNM2 DYN2 Rectum adenocarcinoma Methylation N R785 P50570 1785 DNM2 DYN2 Skin cutaneous melanoma Methylation N R785 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Phosphorylation N S848 P50570 1785 DNM2 DYN2 Myopathy Phosphorylation N S848 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Methylation N R850 P50570 1785 DNM2 DYN2 Myopathy Methylation N R850 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Methylation N R857 P50570 1785 DNM2 DYN2 Myopathy Methylation N R857 P50570 1785 DNM2 DYN2 Charcot-Marie-Tooth disease Methylation N R862 P50570 1785 DNM2 DYN2 Cholangiocarcinoma Methylation N R862 P50570 1785 DNM2 DYN2 Myopathy Methylation N R862 Q13496 4534 MTM1 CG2 Lung adenocarcinoma Ubiquitination N K8 Q13496 4534 MTM1 CG2 Severe X-linked myotubular myopathy Ubiquitination N K8 Q13496 4534 MTM1 CG2 Lung adenocarcinoma Phosphorylation N S13 Q13496 4534 MTM1 CG2 Lung cancer Phosphorylation N S13 Q13496 4534 MTM1 CG2 Severe X-linked myotubular myopathy Phosphorylation N S13 Q13496 4534 MTM1 CG2 Lung adenocarcinoma Phosphorylation N S18 Q13496 4534 MTM1 CG2 Severe X-linked myotubular myopathy Phosphorylation N S18 Q13496 4534 MTM1 CG2 Uterine cancer Phosphorylation N S18 Q13496 4534 MTM1 CG2 Lung adenocarcinoma Ubiquitination N K20 Q13496 4534 MTM1 CG2 Severe X-linked myotubular myopathy Ubiquitination N K20 Q13496 4534 MTM1 CG2 Myopathy Phosphorylation N Y71 Q13496 4534 MTM1 CG2 Myopathy Phosphorylation N S91 Q13496 4534 MTM1 CG2 Severe X-linked myotubular myopathy Ubiquitination N K95 Q13496 4534 MTM1 CG2 Severe X-linked myotubular myopathy Phosphorylation N S106 Q13496 4534 MTM1 CG2 Lung adenocarcinoma Phosphorylation N T112 Q13496 4534 MTM1 CG2 Lung adenocarcinoma Ubiquitination N K114 Q13496 4534 MTM1 CG2 Breast adenocarcinoma Ubiquitination N K124 Q13496 4534 MTM1 CG2 Breast invasive carcinoma Ubiquitination N K124 Q13496 4534 MTM1 CG2 Lung adenocarcinoma Ubiquitination N K124 Q13496 4534 MTM1 CG2 Skin cutaneous melanoma Ubiquitination N K124 Q13496 4534 MTM1 CG2 Stomach adenocarcinoma Ubiquitination N K124 Q13496 4534 MTM1 CG2 Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S147 Q13496 4534 MTM1 CG2 Severe X-linked myotubular myopathy Phosphorylation N S147 Q13496 4534 MTM1 CG2 Skin cutaneous melanoma Phosphorylation N S147 Q13496 4534 MTM1 CG2 Uterine corpus endometrial carcinoma Phosphorylation N S147 Q13496 4534 MTM1 CG2 Breast invasive carcinoma Ubiquitination N K236 Q13496 4534 MTM1 CG2 Myopathy Ubiquitination N K236 Q13496 4534 MTM1 CG2 Severe X-linked myotubular myopathy Ubiquitination N K236 Q13496 4534 MTM1 CG2 Uterine corpus endometrial carcinoma Ubiquitination N K236 Q13496 4534 MTM1 CG2 Hepatocellular carcinoma Ubiquitination N K252 Q13496 4534 MTM1 CG2 Liver cancer Ubiquitination N K252 Q13496 4534 MTM1 CG2 Severe X-linked myotubular myopathy Ubiquitination N K252 Q13496 4534 MTM1 CG2 Skin cutaneous melanoma Ubiquitination N K252 Q13496 4534 MTM1 CG2 Liver cancer Ubiquitination N K255 Q13496 4534 MTM1 CG2 Myopathy Ubiquitination N K259 Q13496 4534 MTM1 CG2 Severe X-linked myotubular myopathy Ubiquitination N K259 Q13496 4534 MTM1 CG2 Skin cutaneous melanoma Ubiquitination N K259 Q13496 4534 MTM1 CG2 Myopathy Phosphorylation N Y260 Q13496 4534 MTM1 CG2 Hepatocellular carcinoma Ubiquitination N K273 Q13496 4534 MTM1 CG2 Myopathy Phosphorylation N Y277 Q13496 4534 MTM1 CG2 Blastoma Phosphorylation N T495 Q13496 4534 MTM1 CG2 Liver cancer Phosphorylation N T495 Q13496 4534 MTM1 CG2 Myopathy Phosphorylation N T495 Q13496 4534 MTM1 CG2 Severe X-linked myotubular myopathy Phosphorylation N T495 Q13496 4534 MTM1 CG2 Severe X-linked myotubular myopathy Phosphorylation N S583 Q13496 4534 MTM1 CG2 Uterine corpus endometrial carcinoma Phosphorylation N S583 Q13496 4534 MTM1 CG2 Severe X-linked myotubular myopathy Phosphorylation N T587 Q13496 4534 MTM1 CG2 Severe X-linked myotubular myopathy Phosphorylation N S588 Q13496 4534 MTM1 CG2 Severe X-linked myotubular myopathy Phosphorylation N S590 Q13496 4534 MTM1 CG2 Severe X-linked myotubular myopathy Phosphorylation N S591 Q13496 4534 MTM1 CG2 Severe X-linked myotubular myopathy Phosphorylation C T601